CA2730697C - Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology - Google Patents

Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology Download PDF

Info

Publication number
CA2730697C
CA2730697C CA2730697A CA2730697A CA2730697C CA 2730697 C CA2730697 C CA 2730697C CA 2730697 A CA2730697 A CA 2730697A CA 2730697 A CA2730697 A CA 2730697A CA 2730697 C CA2730697 C CA 2730697C
Authority
CA
Canada
Prior art keywords
silica sol
sol material
hydrolysis
cells
fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2730697A
Other languages
English (en)
French (fr)
Other versions
CA2730697A1 (en
Inventor
Iwer Baecker
Miranda Rothenburger Glaubitt
Joern Probst
Holger Egger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU SYNECOUN MEDICAL TECHNOLOGY Co Ltd
Original Assignee
JIANGSU SYNECOUN MEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU SYNECOUN MEDICAL TECHNOLOGY Co Ltd filed Critical JIANGSU SYNECOUN MEDICAL TECHNOLOGY Co Ltd
Publication of CA2730697A1 publication Critical patent/CA2730697A1/en
Application granted granted Critical
Publication of CA2730697C publication Critical patent/CA2730697C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/62227—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
    • C04B35/62231—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
    • C04B35/6224—Fibres based on silica
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/40—Metallic constituents or additives not added as binding phase
    • C04B2235/408—Noble metals
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/441—Alkoxides, e.g. methoxide, tert-butoxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Structural Engineering (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Inorganic Fibers (AREA)
  • Silicon Compounds (AREA)
CA2730697A 2008-07-16 2009-07-03 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology Active CA2730697C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008033327A DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102008033327.1 2008-07-16
PCT/EP2009/004806 WO2010006708A1 (de) 2008-07-16 2009-07-03 Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik

Publications (2)

Publication Number Publication Date
CA2730697A1 CA2730697A1 (en) 2010-01-21
CA2730697C true CA2730697C (en) 2016-10-25

Family

ID=41011815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2730697A Active CA2730697C (en) 2008-07-16 2009-07-03 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology

Country Status (13)

Country Link
US (1) US20110123596A1 (cg-RX-API-DMAC7.html)
EP (1) EP2303948B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011527913A (cg-RX-API-DMAC7.html)
KR (1) KR20110039533A (cg-RX-API-DMAC7.html)
CN (1) CN102159623A (cg-RX-API-DMAC7.html)
AU (1) AU2009270515A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0915946A2 (cg-RX-API-DMAC7.html)
CA (1) CA2730697C (cg-RX-API-DMAC7.html)
DE (1) DE102008033327A1 (cg-RX-API-DMAC7.html)
IL (1) IL210313A0 (cg-RX-API-DMAC7.html)
MX (1) MX2011000475A (cg-RX-API-DMAC7.html)
RU (1) RU2512512C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010006708A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010008982A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010023336A1 (de) * 2010-06-10 2011-12-15 Bayer Innovation Gmbh Verfahren zur Herstellung eines Kieselsol-Materials
MX382405B (es) 2010-07-02 2025-03-13 Procter & Gamble Método para suministrar un agente activo.
EP3533908B1 (en) 2010-07-02 2026-07-01 The Procter & Gamble Company NONWOVEN FABRIC COMPRISING ONE OR MORE ACTIVE AGENTS
JP5859526B2 (ja) 2010-07-02 2016-02-10 ザ プロクター アンド ギャンブルカンパニー 活性剤不織布ウェブを含むフィラメント及びその製造方法
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
BR112012033600A2 (pt) * 2010-07-02 2016-11-29 Procter & Gamble Comapny filamentos compreendendo mantas de não-tecido com agente ingerível e métodos de fabricação dos mesmos.
US20140065221A1 (en) * 2011-03-31 2014-03-06 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
FI20155779A7 (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
CN110191700A (zh) 2017-01-27 2019-08-30 宝洁公司 可溶性固体结构形式的组合物
CN110167639B (zh) 2017-01-27 2022-10-14 宝洁公司 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物
JP6923673B2 (ja) 2017-05-16 2021-08-25 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 溶解性固形構造体の形態のコンディショニングヘアケア組成物
DE102017009989A1 (de) * 2017-10-26 2019-05-02 Carl Freudenberg Kg Biokompatibles Verbundmaterial zum Einbringen in einen menschlichen Körper
US20190255223A1 (en) * 2018-02-16 2019-08-22 American Nano, LLC Silica fiber compositions and methods of use
CN108283707B (zh) * 2018-04-05 2021-03-26 广西中医药大学 一种瑶药退烧贴及其制备方法
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
JP7381613B2 (ja) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー アニオン性界面活性剤を含有する溶解性固体繊維性物品
WO2022027067A1 (en) 2020-07-31 2022-02-03 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
CN113332488A (zh) * 2021-05-31 2021-09-03 南昌智产科技有限公司 一种医用硅凝胶泡沫敷料及其制备方法
EP4395730A1 (en) 2021-08-30 2024-07-10 The Procter & Gamble Company Dissolvable solid structure comprising first and second polymeric structurants
US12576013B2 (en) 2021-12-17 2026-03-17 The Procter & Gamble Company Dissolvable solid fibrous shampoo articles containing salts
CN114404660A (zh) * 2022-01-21 2022-04-29 江苏信立康医疗科技有限公司 一种基于三维支架的细胞培养方法
US12540238B2 (en) 2022-03-10 2026-02-03 The Procter & Gamble Company Dissolvable solid structure having first and second layers
CN115531592A (zh) * 2022-10-27 2022-12-30 李升红 一种实现皮肤高效修复的皮肤敷料及其制备方法
DE102023208022A1 (de) * 2023-08-22 2025-02-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Kieselsäure freisetzende faser oder faserfragmente, hieraus hergestellte faservliese sowie formulierung
DE102024209914A1 (de) 2024-10-11 2026-04-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Lösung zur Herstellung einer bioabbaubaren Beschichtung, Verfahren zu ihrer Herstellung, Verfahren zur Beschichtung eines Substrates sowie damit hergestellter beschichteter Gegenstand

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
NZ332968A (en) * 1996-05-29 2000-08-25 Bioxid Oy A controllably dissolvable silica-xerogel prepared via sol-gel
CA2328614C (en) * 1999-02-12 2012-06-26 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
AU764663C (en) * 1999-02-22 2005-02-03 Bayer Innovation Gmbh Biodegradable ceramic fibres from silica sols
US7118921B1 (en) * 1999-06-24 2006-10-10 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
CA2377560C (en) * 1999-06-24 2010-08-24 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
DE10126137C1 (de) * 2001-05-29 2002-11-07 Andreas Haisch Verfahren zur Herstellung von Zellen, Geweben und Organen
DE102004063599B4 (de) 2004-12-30 2007-07-12 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
EP2111417B1 (de) * 2007-01-16 2011-11-30 Basf Se Verfahren zur herstellung von polymerpartikeln durch polymerisation von flüssigkeitstropfen in einer gasphase

Also Published As

Publication number Publication date
DE102008033327A1 (de) 2010-01-21
RU2011105299A (ru) 2012-08-27
WO2010006708A1 (de) 2010-01-21
US20110123596A1 (en) 2011-05-26
IL210313A0 (en) 2011-03-31
BRPI0915946A2 (pt) 2019-04-09
CA2730697A1 (en) 2010-01-21
EP2303948B1 (de) 2018-09-12
CN102159623A (zh) 2011-08-17
RU2512512C2 (ru) 2014-04-10
MX2011000475A (es) 2011-03-15
AU2009270515A1 (en) 2010-01-21
JP2011527913A (ja) 2011-11-10
KR20110039533A (ko) 2011-04-19
EP2303948A1 (de) 2011-04-06

Similar Documents

Publication Publication Date Title
US20110123596A1 (en) Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
US9862940B2 (en) Silica sol material for producing bilogically degradable and/or resorbable silica gel materials, the production and use thereof
Zhu et al. Incorporation of ZnO/bioactive glass nanoparticles into alginate/chitosan composite hydrogels for wound closure
Ghasempour et al. Biomimetic scaffolds loaded with mesenchymal stem cells (MSCs) or MSC-derived exosomes for enhanced wound healing
Kouhi et al. Injectable gellan gum/lignocellulose nanofibrils hydrogels enriched with melatonin loaded forsterite nanoparticles for cartilage tissue engineering: Fabrication, characterization and cell culture studies
Zhang et al. A novel nanosilver/nanosilica hydrogel for bone regeneration in infected bone defects
Wang et al. Fabrication of an exosome-loaded thermosensitive chitin-based hydrogel for dental pulp regeneration
Li et al. Advances in biomaterials for oral-maxillofacial bone regeneration: spotlight on periodontal and alveolar bone strategies
Datta et al. Oleoyl-chitosan-based nanofiber mats impregnated with amniotic membrane derived stem cells for accelerated full-thickness excisional wound healing
TW200403268A (en) Biodegradable polyurethane/urea compositions
US20120183622A1 (en) Encapsulated cells and composites thereof
Hou et al. Oppositely charged polyurethane microspheres with tunable zeta potentials as an injectable dual-loaded system for bone repair
Peifen et al. New skin tissue engineering scaffold with sulfated silk fibroin/chitosan/hydroxyapatite and its application
Sun et al. A novel gelatin/carboxymethyl chitosan/nano-hydroxyapatite/β-tricalcium phosphate biomimetic nanocomposite scaffold for bone tissue engineering applications
CN103877621B (zh) 一种电纺纤维增强磷酸钙骨水泥复合材料及其应用
JP2023508917A (ja) 生体適合性材料
Guo et al. An injectable, self-healing, anti-infective, and anti-inflammatory novel glycyrrhizic acid hydrogel for promoting acute wound healing and regeneration
Nie et al. Schiff base formed functional hydrogel dressing via ϵ-poly-L-lysine modified chitosan and oxidized dextran with the incorporation of epigallocatechin-3-gallate
Kesharwani et al. Polymer based biofilms: development and clinical application in medical science
Pingale et al. Biomaterials-Based Additive Manufacturing of Veterinary Products
Ding Development of electrospun poly-3-hydroxybutyrate-based composite and hybrid scaffolds for bone tissue engineering
Çakmen et al. Fabrication and characterization of high molecular mass tmpe-based polyurethane wound dressing materials containing allantoin and gentamicin by electrospinning
HK1139120A (en) Silica sol material for producing biologically degradable and/or resorbable silica gel materials, the production and use thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140604

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250625

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250625